All blog posts
Total 51 results for
Showing 12 out of 51 results
12 三月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
18 八月 2025
Pharma remains an enforcement focus in China – SAMR orders unwinding of a completed pharma deal
18 三月 2025
Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
30 一月 2025
The UPC at 18 months
15 八月 2024
H1 2024 – a steady start for biopharma M&A
16 七月 2024
UPC revokes Amgen's patent in the first case filed at the UPC
02 七月 2024
Recent additions to Life Sciences Notes
28 六月 2024
Overview of EU regulatory and competition law in the Pharma sector
12 四月 2024
HSF Patent team named best in Europe by Managing IP
13 三月 2024
Recent additions to Life Sciences Notes
19 二月 2024
Five Years of Activity in a Priority Sector: The European Commission's Report on Competition Enforcement in the Pharmaceutical Sector (2018-2022)
12 一月 2024
The UPC – 2023's achievements and predictions for 2024
Showing 12 out of 51 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group